Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MIR142 host gene (MIR142HG) encodes a long non-coding RNA that is the primary transcript for microRNA-142, highly specific to the hematopoietic lineage. Mature miR-142 (produced from MIR142HG) is a post-transcriptional gene expression regulator that controls critical processes in immune cell differentiation, function, and homeostasis, as well as hemostasis. The gene is highly conserved and both the 3p and 5p strands of miR-142 are functionally important. MIR142HG mutations, especially those affecting the seed regions of miR-142-3p, are implicated in the pathogenesis of multiple hematological malignancies, including leukemia and lymphoma, and impact immune regulation and hematopoietic lineage development. While MIR142HG itself is not a traditional drug target, the mature miR-142 produced from it is emerging as a potential target for oligonucleotide therapeutics in oncology and immune modulation[10][3][2][4][12][7][5].
For miR-142 mimics or inhibitors: Sequence-specific binding to miR-142-3p/5p to restore or inhibit microRNA function, altering post-transcriptional gene regulation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR142 host gene (MIR142HG).